IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Seelos Therapeutics Inc

CUSIP: 81577F208 | 46 institutional holders

Quarters

Q2 2024Q1 2024Q4 2023
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2024

Hollencrest Capital Management10
0.0% of portfolio›$6
Parallel Advisors, LLC3
0.0% of portfolio›$2
StyleTurnoverLocationFiled
Hollencrest Capital Management
10$60.0%ETFLowNewport Beach, CA2024-08-13
Parallel Advisors, LLC
3$20.0%IndexLowSan Francisco, CA2024-08-08